ICD-10-CM Billable Code

Z52.011

Autologous donor, stem cells

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code Z52.011 is used to classify situations involving autologous stem cell donation. This refers to the process where a patient donates their own stem cells for medical treatments, particularly in cases like bone marrow transplants. These stem cells can be collected from blood or bone marrow and stored for future use, often to treat conditions such as certain cancers or blood disorders. This procedure plays a crucial role in regenerative medicine and personalized therapies, offering patients a way to receive high-dose treatments while minimizing immune rejection risk.

Causes & Symptoms

Clinical Causes: Diagnosis of blood cancers such as multiple myeloma, lymphoma, or leukemia Treatment of certain blood and immune system disorders like aplastic anemia or autoimmune diseases Preparation for autologous stem cell transplantation following high-dose chemotherapy or radiation therapy Conditions requiring regenerative therapies utilizing the patient’s own stem cells

Key Symptoms: Symptoms related to underlying disease, like fatigue, infections, or anemia Physical effects of prior treatments, such as hair loss or nausea Signs of complication from the collection process, which can include pain or discomfort at the collection site No specific symptoms directly caused by the donation procedure itself; most are related to the recipient's underlying condition or treatment effects

Diagnostic & Treatment

Diagnosis Path: The process of diagnosing the need for autologous stem cell collection involves a combination of laboratory tests, imaging studies, and assessments of the patient's overall health. Blood counts and marrow evaluations are conducted to determine stem cell availability and suitability. Prior medical history and disease assessments guide the decision to proceed with collection and transplantation. The identification of a patient as an autologous donor is based on ensuring the collected stem cells meet quality and quantity standards for treatment.

Treatment Protocols: The treatment process involves several stages:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Z52.011 a billable ICD-10 code?
Yes, Z52.011 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Z52.011?
Clinical documentation must specify the nature of Autologous donor, stem cells and any associated comorbidities for accurate reporting.

Cite this Clinical Reference